Important signaling pathways altered in gliomas include the growth factor receptor tyrosine kinase (RTK) signaling pathways, partly as a result of PDGF and EGFR overexpression (Verhaak et al., 2010; Nazarenko et al., 2012). Here, EGFR is linked to central nervous system cancer.